Eli Lilly & Co. News, Eli Lilly & Co. Quote, LLY Quote

Eli Lilly & Co. (NY:LLY) Delayed: 1147.02 -12.58 (1.08%)

Prev. Close

$1159.60

Today 6M 1Y 5Y

Open

$1150.61

52 Wk High

$88.16

52 Wk Low

$67.88

Day High

$1158.44

Day Low

$1138.31

P/E

265.51

EPS

$4.32

Volume

1,327,494

Friends, Peers and Foes (?): NVO, PFE, HIMS, ABBV, MRK (more...)

ALERTS | RSS

Sep 3, 2026 05:25 AM Bessent at Charlotte Private Luncheon warns China AI win would 'negate all else', targets 80% compute share by 2028
Sep 2, 2026 09:29 AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)
Sep 1, 2026 10:00 AM Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference
Sep 1, 2026 09:14 AM BMO Capital: 'Eli Lilly (LLY) to Acquire Precision I&I Biotech Merida Bio'
Aug 31, 2026 07:01 AM Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease
Aug 31, 2026 07:00 AM New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Aug 31, 2026 06:45 AM Lilly to buy Merida Biosciences for up to $2.875 billion
Aug 31, 2026 06:45 AM Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Aug 28, 2026 07:00 AM FDA clears Lilly's Mounjaro for cardiovascular risk in type 2 diabetes
Aug 28, 2026 07:00 AM FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

Entities mentioned with LLY

View All Entities